X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
| Molecular Weight | 182.18 g/mol |
|---|---|
| Molecular Formula | C6H10N6O |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 182.09160896 g/mol |
| Monoisotopic Mass | 182.09160896 g/mol |
| Topological Polar Surface Area | 95.4 A^2 |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 302 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 4 | |
|---|---|
| Drug Name | Dacarbazine |
| PubMed Health | Dacarbazine (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | Dacarbazine for injection, USP is a colorless to an ivory colored solid which is light sensitive. Each 20 mL vial contains 200 mg of dacarbazine (active ingredient). Each vial also contains anhydrous citric acid and mannitol. Dacarbazine for injectio... |
| Active Ingredient | Dacarbazine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 500mg/vial; 100mg/vial; 200mg/vial |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa; Hospira; Teva Pharms Usa; Eurohlth Intl |
| 2 of 4 | |
|---|---|
| Drug Name | Dtic-dome |
| Active Ingredient | Dacarbazine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 100mg/vial; 200mg/vial |
| Market Status | Prescription |
| Company | Bayer Hlthcare |
| 3 of 4 | |
|---|---|
| Drug Name | Dacarbazine |
| PubMed Health | Dacarbazine (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | Dacarbazine for injection, USP is a colorless to an ivory colored solid which is light sensitive. Each 20 mL vial contains 200 mg of dacarbazine (active ingredient). Each vial also contains anhydrous citric acid and mannitol. Dacarbazine for injectio... |
| Active Ingredient | Dacarbazine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 500mg/vial; 100mg/vial; 200mg/vial |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa; Hospira; Teva Pharms Usa; Eurohlth Intl |
| 4 of 4 | |
|---|---|
| Drug Name | Dtic-dome |
| Active Ingredient | Dacarbazine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 100mg/vial; 200mg/vial |
| Market Status | Prescription |
| Company | Bayer Hlthcare |
Market Place
